We hypothesized that a standardized, concentrated with added macronutrients parenteral nutrition regimen would improve neurodevelopmental outcomes.
This study assessed the exposure to phthalates of preterm neonates who received total parenteral nutrition during their stay in the neonatal intensive care unit and the risk of neurodevelopment delays at the age of 2 months.
Fluid, electrolyte, and neurodevelopment data in a cohort of extremely preterm infants randomly assigned to receive either one day (early feeding group) or four days (late feeding group) of trophic feeding volumes.
A randomized trial reporting the effects of the early progression of feeding volumes on fluid balance and neurodevelopment among infants born extremely preterm.
The study was to determine whether infants randomized to an enhanced parenteral nutrition protocol had improved developmental outcomes at 4, 12, or 24 months corrected age.
The objective was to test whether an increased iron dose would be associated with improved neurodevelopment as assessed by the Bayley Scales of Infant Development among infants enrolled in the Preterm Erythropoietin Neuroprotection Trial (PENUT).
The aim of this study was to examine the effects of energy-enhanced parenteral nutrition in the first week of life on long-term neurodevelopment in preterm neonates.
Retrospective study of very preterm infants. Primary outcome was survival without neurodevelopmental impairment at 2 years corrected age.
We compared macronutrient and energy intakes, growth, diseases associated with prematurity, and neurodevelopment in small preterm infants on parenteral nutrition who developed and did not develop hypertriglyceridemia.
The objectives were to determine the association of energy and macronutrient intake to total brain growth and white matter maturation, to examine effect of critical illness, to investigate the relationship with neurodevelopmental outcomes.